Evidence map›Paper›PMID 39496685›Full record

ArticleScientific reports2024

Phloretin attenuates inflammation induced by subarachnoid hemorrhage through regulation of the TLR2/MyD88/NF-kB pathway.

Xudong Hao, Yu Bai, Wei Li, Ming Xing Zhang

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Toll like receptor 4 (TLR4) in neuroinflammation: From acute hemorrhagic stroke to chronic neurodegeneration.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xudong HaoDepartment of Neurosurgery, Shanxi Provincial People's Hospital, Shuangtasi Street, 29, Taiyuan, 030012, China. haoxd2014@sxmu.edu.cn.
Yu BaiComprehensive Examination Department, Children's Hospital of Shanxi, Taiyuan, 030000, China.
Wei LiDepartment of Neurosurgery, Bengbu Third People's Hospital Bengbu, 233000, Anhui, China.
Ming Xing ZhangDepartment of Neurosurgery, Bengbu Third People's Hospital Bengbu, 233000, Anhui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Subarachnoid hemorrhage (SAH), a stroke subtype associated with high mortality, is closely linked to neuroinflammation. Phloretin, a naturally occurring flavonoid abundant in fruits, possesses anti-inflammatory properties. However, its specific role in SAH remains unclear. Therefore, we aimed to investigate the potential role of phloretin in SAH. We established in vitro and in vivo SAH models to assess the effects of phloretin. Subsequently, utilizing SAH-related public datasets from the GEO database, we identified key genes associated with SAH and investigated the potential mechanism of action of phloretin. Our findings reveal that phloretin significantly improves prognostic outcomes and mitigates inflammation in SAH mice. Moreover, our results suggest that phloretin mitigates neuroinflammation by inhibiting the TLR2/MYD88/NF-κB pathway.

Indexed as

Myeloid Differentiation Factor 88NF-kappa BPhloretinSignal TransductionSubarachnoid HemorrhageToll-Like Receptor 2AnimalsAnti-Inflammatory AgentsDisease Models, AnimalHumansInflammationMaleMiceMice, Inbred C57BLAnti-Inflammatory AgentsMyd88 protein, mouseMyeloid Differentiation Factor 88NF-kappa BPhloretinTlr2 protein, mouseToll-Like Receptor 2NeuroinflammationPhloretinSubarachnoid hemorrhage (SAH)TLR2/MYD88/NF-Κb

Identifiers

PMID39496685
PMCPMC11534998

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.